应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02675 精锋医疗-B
休市中 10-02 16:08:09
34.460
-2.400
-6.51%
最高
35.060
最低
34.000
成交量
5.99万
今开
35.060
昨收
36.860
日振幅
2.88%
总市值
134.39亿
流通市值
112.34亿
总股本
3.90亿
成交额
206.26万
换手率
0.02%
流通股本
3.26亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
精锋医疗-B 2026年9月股份变动月报:回购411,900股,总股本保持不变
公告速递 · 10-02 16:36
精锋医疗-B 2026年9月股份变动月报:回购411,900股,总股本保持不变
港股异动 | 精锋医疗-B(02675)午后涨超5% 精锋®多孔腔镜手术机器人在新加坡FPH顺利投入临床使用
智通财经 · 09-30 13:42
港股异动 | 精锋医疗-B(02675)午后涨超5% 精锋®多孔腔镜手术机器人在新加坡FPH顺利投入临床使用
精锋医疗-B 2026年中期营收3.19亿元,经调整净亏损0.19亿元
公告速递 · 09-23
精锋医疗-B 2026年中期营收3.19亿元,经调整净亏损0.19亿元
港股异动 | 精锋医疗-B(02675)盘中涨超4% 公司已正式启动A股上市辅导
智通财经 · 09-22
港股异动 | 精锋医疗-B(02675)盘中涨超4% 公司已正式启动A股上市辅导
精锋医疗-B拟发行人民币股份 已提交上市前辅导的登记申请
新浪港股 · 09-14
精锋医疗-B拟发行人民币股份 已提交上市前辅导的登记申请
精锋医疗-B(02675)启动A股上市前筹备 已提交上市辅导备案
公告速递 · 09-11
精锋医疗-B(02675)启动A股上市前筹备 已提交上市辅导备案
精锋医疗-B(02675)拟发行人民币股份 已提交上市前辅导的登记申请
智通财经 · 09-11
精锋医疗-B(02675)拟发行人民币股份 已提交上市前辅导的登记申请
港股异动 | 精锋医疗-B(02675)涨超8% 上半年收入翻倍亏损收窄近八成 海内外手术机器人销售迅速增长
智通财经 · 09-07
港股异动 | 精锋医疗-B(02675)涨超8% 上半年收入翻倍亏损收窄近八成 海内外手术机器人销售迅速增长
精锋医疗-B(02675):9月4日回购2.4万股,耗资约81.54万港元
公告速递 · 09-04
精锋医疗-B(02675):9月4日回购2.4万股,耗资约81.54万港元
精锋医疗-B(02675.HK)9月4日耗资约81.54万港元回购2.4万股
智通财经 · 09-04
精锋医疗-B(02675.HK)9月4日耗资约81.54万港元回购2.4万股
精锋医疗-B(02675)9月4日耗资约81.54万港元回购2.4万股
智通财经 · 09-04
精锋医疗-B(02675)9月4日耗资约81.54万港元回购2.4万股
精锋医疗-B8月股份变动月报:股本维持稳定
公告速递 · 09-04
精锋医疗-B8月股份变动月报:股本维持稳定
精锋医疗-B于9月3日回购8.29万股,涉资约268.27万港元
公告速递 · 09-03
精锋医疗-B于9月3日回购8.29万股,涉资约268.27万港元
精锋医疗-B回购30.5万股股份,涉资约984.22万港元
公告速递 · 09-02
精锋医疗-B回购30.5万股股份,涉资约984.22万港元
精锋医疗-B(02675.HK)9月2日斥资984.22万港元回购30.5万股
智通财经 · 09-02
精锋医疗-B(02675.HK)9月2日斥资984.22万港元回购30.5万股
精锋医疗-B(02675)8月31日回购2.56万股股份,总额约89.29万港元
公告速递 · 08-31
精锋医疗-B(02675)8月31日回购2.56万股股份,总额约89.29万港元
精锋医疗-B(02675)8月31日斥资89.29万港元回购2.56万股
智通财经 · 08-31
精锋医疗-B(02675)8月31日斥资89.29万港元回购2.56万股
精锋医疗-B(02675)发布中期业绩,股东应占亏损1925.4万元 同比减少78.4%
智通财经 · 08-29
精锋医疗-B(02675)发布中期业绩,股东应占亏损1925.4万元 同比减少78.4%
精锋医疗-B2026年中期财报:营收3.19亿元
公告速递 · 08-28
精锋医疗-B2026年中期财报:营收3.19亿元
财报前瞻|精锋医疗-B盘后披露中期业绩,机构观点偏多
财报Agent · 08-21
财报前瞻|精锋医疗-B盘后披露中期业绩,机构观点偏多
加载更多
公司概况
公司名称:
精锋医疗-B
所属市场:
SEHK
上市日期:
--
主营业务:
深圳市精锋医疗科技股份有限公司是一家主要从事设计、开发及制造手术机器人的中国公司。该公司的主要产品包括“精锋”多孔腔镜手术机器人、“精锋”单孔腔镜手术机器人和精锋支气管镜机器人。“精锋”多孔腔镜手术机器人是一种机器人辅助设备,用于进行微创手术(MIS),使用机器人、成像技术和数字技术,应用范围涵盖泌尿科、妇科、普外科及胸外科。“精锋”单孔腔镜手术机器人是一种机器人辅助设备,用于通过单个小切口或自然腔道进行微创手术,应用范围涵盖泌尿科、妇科及普外科。该公司在中国国内市场及海外市场开展业务。
发行价格:
--
{"stockData":{"symbol":"02675","market":"HK","secType":"STK","nameCN":"精锋医疗-B","latestPrice":34.46,"timestamp":1790928489006,"preClose":36.86,"halted":0,"volume":59900,"delay":0,"changeRate":-0.06511123168746605,"floatShares":326000000,"shares":390000000,"eps":-0.24613,"marketStatus":"休市中","change":-2.4,"latestTime":"10-02 16:08:09","open":35.06,"high":35.06,"low":34,"amount":2062564,"amplitude":0.028757,"askPrice":34.46,"askSize":100,"bidPrice":34.36,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.056,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791163800000},"marketStatusCode":7,"adr":0,"listingDate":1767801600000,"exchange":"SEHK","adjPreClose":36.86,"openAndCloseTimeList":[[1790904600000,1790913600000],[1790917200000,1790928000000]],"volumeRatio":0.3561245089176346,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02675","defaultTab":"news","newsList":[{"id":"1125483928","title":"精锋医疗-B 2026年9月股份变动月报:回购411,900股,总股本保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1125483928","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1125483928?lang=zh_cn&edition=full","pubTime":"2026-10-02 16:36","pubTimestamp":1790930161,"startTime":"0","endTime":"0","summary":"2026年10月2日,深圳市精锋医疗科技股份有限公司发布截至2026年9月30日的股份变动月报表。报告期内,上述注册股本结构无变化,H股与未上市股份的数量分别保持为327,761,248股和64,119,252股。已发行股份方面,9月末H股实际已发行股份数为325,497,848股,库存股数量为2,263,400股,与上月底相比,已发行股份减少411,900股,库存股份则增加411,900股。公司于2026年9月2日、9月3日和9月4日分别回购股份305,000股、82,900股和24,000股,回购价格分别为每股32.2695港元、32.3605港元和33.9744港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671278518","title":"港股异动 | 精锋医疗-B(02675)午后涨超5% 精锋®多孔腔镜手术机器人在新加坡FPH顺利投入临床使用","url":"https://stock-news.laohu8.com/highlight/detail?id=2671278518","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671278518?lang=zh_cn&edition=full","pubTime":"2026-09-30 13:42","pubTimestamp":1790746926,"startTime":"0","endTime":"0","summary":"消息面上,据精锋医疗官微消息,近日,精锋医疗全球化商业进程迎来重大里程碑突破——自主研发的精锋多孔腔镜手术机器人在新加坡 Farrer Park Hospital完成商业化装机,并顺利投入临床使用。值得一提的是,精锋机器人此次落地FPH并顺利开展首台手术,成为第一个在新加坡实现商业化装机的中国品牌腔镜手术机器人。截至目前,精锋多孔腔镜手术机器人已获得全球60多个国家和地区的市场准入,海外装机覆盖欧洲、亚太、中东、非洲及南美等多个区域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502539.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4193","STmain","KCAI","VXUS","BK1100","02675","HTEC","BK4588","MDEV","FPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192518169","title":"精锋医疗-B 2026年中期营收3.19亿元,经调整净亏损0.19亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1192518169","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192518169?lang=zh_cn&edition=full","pubTime":"2026-09-23 22:52","pubTimestamp":1790175128,"startTime":"0","endTime":"0","summary":"根据精锋医疗-B公告,截至2026年6月30日止六个月,公司实现营收3.19亿元人民币,同比增长113.8%。报告期内毛利约2.05亿元,同比增长118.0%,毛利率上升至64.1%。经调整净亏损0.19亿元,同比收窄78.4%。公告显示,公司通过商业化规模扩张,以及加强经营效率管控,大幅提升了业绩表现。从成本结构看,研发投入达0.54亿元,同比下降44.2%,销售及营销费用为0.88亿元,同比增长49.1%。公告显示,报告期内国内和海外市场均实现增长,海外市场收入占比达到69.8%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"精锋医疗-B 2026年中期营收3.19亿元,经调整净亏损0.19亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669189041","title":"港股异动 | 精锋医疗-B(02675)盘中涨超4% 公司已正式启动A股上市辅导","url":"https://stock-news.laohu8.com/highlight/detail?id=2669189041","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669189041?lang=zh_cn&edition=full","pubTime":"2026-09-22 11:48","pubTimestamp":1790048906,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,精锋医疗-B(02675)盘中涨超4%,截至发稿,涨3.1%,报36.64港元,成交额663.61万港元。消息面上,9月22日,据证监会官网显示,深圳市精锋医疗科技股份有限公司于9月21日正式启动上市辅导,中信证券担任该公司辅导机构。此前,精锋医疗-B公告称,公司将探究拟发行人民币股份的初步建议,启动在A股市场首次公开发行人民币普通股及上市的计划(建议A股上市)。建议发行人民币股份取决于及受限于(其中包括)市场状况、董事会的进一步批准、公司股东于股东大会上的批准及必要监管机构的批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1499187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","82846","399300","BK4588","KCAI","83188","02675","83130","BK1100","07233","BK1147","03130","02846","02827","VXUS","IPOS","159982","03188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667636217","title":"精锋医疗-B拟发行人民币股份 已提交上市前辅导的登记申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2667636217","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667636217?lang=zh_cn&edition=full","pubTime":"2026-09-14 08:45","pubTimestamp":1789346700,"startTime":"0","endTime":"0","summary":"热点栏目自选股\n数据中心\n行情中心\n资金流向\n模拟交易客户端精锋医疗-B(02675)公布,公司将探究拟发行人民币股份的初步建议,启动在A股市场首次公开发行人民币普通股及上市的计划(建议A股上市)。建议发行人民币股份取决于及受限于(其中包括)市场状况、董事会的进一步批准、公司股东于股东大会上的批准及必要监管机构的批准。就建议A股上市而言,公司已委聘上市前辅导机构,并于2026年9月11日提交上市前辅导的登记申请。于本公告日期,除本文所披露的资料外,董事会尚未批准有关建议A股上市的其他计划,亦未就建议A股上市向中国或任何其他地区的相关监管机构提出任何申请。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-09-14/doc-iniruark4803987.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IPOS","02675","MCNHmain","BK1100","CNHmain","UCmain","CYB","MUCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152174498","title":"精锋医疗-B(02675)启动A股上市前筹备 已提交上市辅导备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1152174498","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1152174498?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:25","pubTimestamp":1789136742,"startTime":"0","endTime":"0","summary":"2026年9月11日,精锋医疗-B发布内幕消息公告称,公司拟在A股市场首次公开发行人民币普通股并上市,已就此启动相关筹备工作。公司已委聘上市前辅导机构,并于2026年9月11日向有关部门提交上市前辅导登记申请。公司提醒投资者,建议A股上市尚无保证一定实施,相关进展将按香港联合交易所有限公司证券上市规则及其他适用法规及时披露。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666621578","title":"精锋医疗-B(02675)拟发行人民币股份 已提交上市前辅导的登记申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2666621578","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666621578?lang=zh_cn&edition=full","pubTime":"2026-09-11 22:24","pubTimestamp":1789136669,"startTime":"0","endTime":"0","summary":"智通财经APP讯,精锋医疗-B(02675)公布,公司将探究拟发行人民币股份的初步建议,启动在A股市场首次公开发行人民币普通股及上市的计划(建议A股上市)。建议发行人民币股份取决于及受限于(其中包括)市场状况、董事会的进一步批准、公司股东于股东大会上的批准及必要监管机构的批准。就建议A股上市而言,公司已委聘上市前辅导机构,并于2026年9月11日提交上市前辅导的登记申请。于本公告日期,除本文所披露的资料外,董事会尚未批准有关建议A股上市的其他计划,亦未就建议A股上市向中国或任何其他地区的相关监管机构提出任何申请。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495265.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IPOS","02675","MCNHmain","BK1100","CNHmain","UCmain","CYB","MUCmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392808","title":"港股异动 | 精锋医疗-B(02675)涨超8% 上半年收入翻倍亏损收窄近八成 海内外手术机器人销售迅速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392808","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665392808?lang=zh_cn&edition=full","pubTime":"2026-09-07 14:46","pubTimestamp":1788763572,"startTime":"0","endTime":"0","summary":"消息面上,精锋医疗此前披露的2026年中期业绩显示,今年上半年,公司实现收入人民币3.19亿元,同比增加113.8%,主要由于手术机器人于国内外市场的销售迅速增长,其中来自销售予海外终端用户的产品收入达2.22亿元,占总收入的约69.8%;公司权益股东应占亏损1925.4万元,同比减少78.4%。截至上半年,公司已在全球安装或交付158台手术机器人,其中中国及海外终端用户分别安装或交付55台及103台。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492706.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HTEC","VXUS","MDEV","BK1100","BK4588","BK4585","KCAI","02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111431952","title":"精锋医疗-B(02675):9月4日回购2.4万股,耗资约81.54万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111431952","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111431952?lang=zh_cn&edition=full","pubTime":"2026-09-04 19:52","pubTimestamp":1788522739,"startTime":"0","endTime":"0","summary":"2026年9月4日,深圳市精锋医疗科技股份有限公司发布公告称,公司于当日通过香港联交所场内回购股份。根据公告,精锋医疗-B回购股份数量为24,000股,占本次回购前公司已发行股份总数325,521,848股的约0.0074%。本次回购每股价格介于每股港币33.66元至港币34元,总成交金额为港币815,386元,折合约81.54万港元。公司确认,此次回购股份相关程序已经过董事会批准,并严格遵守了香港联合交易所有限公司证券上市规则及其他相关法律法规。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"精锋医疗-B(02675):9月4日回购2.4万股,耗资约81.54万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664390743","title":"精锋医疗-B(02675.HK)9月4日耗资约81.54万港元回购2.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664390743","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664390743?lang=zh_cn&edition=full","pubTime":"2026-09-04 19:51","pubTimestamp":1788522669,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339072","title":"精锋医疗-B(02675)9月4日耗资约81.54万港元回购2.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339072","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664339072?lang=zh_cn&edition=full","pubTime":"2026-09-04 19:51","pubTimestamp":1788522669,"startTime":"0","endTime":"0","summary":"智通财经APP讯,精锋医疗-B(02675)公布,2026年9月4日耗资约81.54万港元回购2.4万股股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492290.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112291294","title":"精锋医疗-B8月股份变动月报:股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1112291294","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112291294?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:46","pubTimestamp":1788515206,"startTime":"0","endTime":"0","summary":"深圳市精锋医疗科技股份有限公司于2026年9月4日公布了截至2026年8月31日的股份变动月报表。报告显示,公司注册股本维持人民币391,880,500元不变,其中H股注册股本为人民币327,761,248元,未上市股份注册股本为人民币64,119,252元,两者均无增减变化。该回购已获得2026年6月25日股东大会批准,回购股份并未注销,转为公司库藏股持有。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158883440","title":"精锋医疗-B于9月3日回购8.29万股,涉资约268.27万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158883440","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1158883440?lang=zh_cn&edition=full","pubTime":"2026-09-03 20:06","pubTimestamp":1788437183,"startTime":"0","endTime":"0","summary":"深圳市精锋医疗科技股份有限公司于2026年9月3日发布公告,披露在香港联合交易所回购股份的相关信息。公告显示,精锋医疗-B于2026年9月3日回购82,900股H股,占回购发生前公司已发行股份总数的约0.0255%。此次回购价格介于每股32.00港元至32.50港元之间,总耗资约268.27万港元。根据公告,此次股份回购获得公司于2026年6月25日股东大会通过的购回授权。公司在公告中确认,所有回购行为均符合香港联合交易所上市规则及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"精锋医疗-B于9月3日回购8.29万股,涉资约268.27万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146334948","title":"精锋医疗-B回购30.5万股股份,涉资约984.22万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146334948","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146334948?lang=zh_cn&edition=full","pubTime":"2026-09-02 20:16","pubTimestamp":1788351404,"startTime":"0","endTime":"0","summary":"深圳市精锋医疗科技股份有限公司于2026年9月2日公告,宣布在香港联交所场内回购股份30.5万股,约占该公司回购前已发行股份总数的0.0936%,回购价格区间介乎每股31.88港元至32.50港元,合计支付约984.22万港元。完成此次回购后,公司已发行股份总数维持为327,761,248股,其中325,604,748股为已发行股份,库藏股份数增至2,156,500股。本次回购后,新股发行或再次出售、转让库藏股份的相关暂止期截至2026年10月2日。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"精锋医疗-B回购30.5万股股份,涉资约984.22万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664310811","title":"精锋医疗-B(02675.HK)9月2日斥资984.22万港元回购30.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664310811","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664310811?lang=zh_cn&edition=full","pubTime":"2026-09-02 20:14","pubTimestamp":1788351258,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199695755","title":"精锋医疗-B(02675)8月31日回购2.56万股股份,总额约89.29万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1199695755","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199695755?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:45","pubTimestamp":1788173157,"startTime":"0","endTime":"0","summary":"深圳市精锋医疗科技股份有限公司于2026年8月31日发布翌日披露报表,公布当日在香港联交所场内回购25,600股H股普通股,占回购前公司已发行股份约0.0079%。本次回购价格介乎每股港币34.24至35.00港元,总金额约89.29万港元。公司股东于2026年6月25日通过回购授权,可回购32,614,504股,至今已在交易所回购235,300股。根据公告,回购股份后新股发行及库存股出售的暂止期截至2026年9月30日。公告由联席公司秘书吴梦媛签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"精锋医疗-B(02675)8月31日回购2.56万股股份,总额约89.29万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663072555","title":"精锋医疗-B(02675)8月31日斥资89.29万港元回购2.56万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2663072555","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663072555?lang=zh_cn&edition=full","pubTime":"2026-08-31 18:43","pubTimestamp":1788173030,"startTime":"0","endTime":"0","summary":"智通财经APP讯,精锋医疗-B(02675)发布公告,于2026年8月31日,该公司斥资89.29万港元回购2.56万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489625.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02675","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663970810","title":"精锋医疗-B(02675)发布中期业绩,股东应占亏损1925.4万元 同比减少78.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663970810","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663970810?lang=zh_cn&edition=full","pubTime":"2026-08-29 00:46","pubTimestamp":1787935567,"startTime":"0","endTime":"0","summary":"智通财经APP讯,精锋医疗-B(02675)发布截至2026年6月30日止六个月中期业绩,该集团取得收入人民币3.19亿元(单位下同),同比增加113.8%;本公司权益股东应占亏损1925.4万元,同比减少78.4%;每股亏损0.05元。公告称,收入增加主要是由于精锋®多孔腔镜手术机器人国外销量大幅增加。国外销量大幅增加的主要原因是集团已建立海外销售团队及确立了分销商协议,基于集团的手术机器人的性能、临床稳定性以及营销举措,精锋®多孔腔镜手术机器人于海外市场的商业化贡献了较大的收入增幅。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488810.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164701536","title":"精锋医疗-B2026年中期财报:营收3.19亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1164701536","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164701536?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:46","pubTimestamp":1787928419,"startTime":"0","endTime":"0","summary":"2026年上半年,精锋医疗-B实现营收3.19亿元,同比增长113.8%。同期毛利达到2.05亿元,同比增长118%,毛利率为64.1%,较上年同期提升1.3个百分点。从成本结构看,2026年上半年研发投入为5384.1万元,占营收比重约16.9%,较上年同期减少44.2%,销售及营销费用为8746万元,同比上升49.1%,占营收约27.4%,管理费用为2649.8万元,同比下降32.7%,占营收约8.3%。境内市场收入约0.96亿元,同比增长约8.8%,主要来自腔镜手术机器人在多学科应用的持续拓展。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"精锋医疗-B2026年中期财报:营收3.19亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119535906","title":"财报前瞻|精锋医疗-B盘后披露中期业绩,机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1119535906","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1119535906?lang=zh_cn&edition=full","pubTime":"2026-08-21 10:55","pubTimestamp":1787280919,"startTime":"0","endTime":"0","summary":"精锋医疗-B将于2026年08月28日(盘后)公布截至2026年06月30日止中期业绩,市场关注商业化放量、海外准入与资本运作的联动影响。目前未见权威一致预期披露,公司上一季度文件亦未给出针对本季度的营收、毛利率、净利润或净利率、调整后每股收益等量化指引,故本节不展示具体预测数据;公司董事会已安排在2026年08月28日审议中期业绩并对外发布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻|精锋医疗-B盘后披露中期业绩,机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02675"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.edgemedical.cn","stockEarnings":[{"period":"1week","weight":-0.0188},{"period":"1month","weight":0.0702},{"period":"3month","weight":-0.2232},{"period":"6month","weight":-0.3933},{"period":"1year","weight":-0.2031},{"period":"ytd","weight":-0.2031}],"compareEarnings":[{"period":"1week","weight":-0.0219},{"period":"1month","weight":-0.0529},{"period":"3month","weight":0.0266},{"period":"6month","weight":-0.0456},{"period":"1year","weight":-0.1215},{"period":"ytd","weight":-0.0647}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"深圳市精锋医疗科技股份有限公司是一家主要从事设计、开发及制造手术机器人的中国公司。该公司的主要产品包括“精锋”多孔腔镜手术机器人、“精锋”单孔腔镜手术机器人和精锋支气管镜机器人。“精锋”多孔腔镜手术机器人是一种机器人辅助设备,用于进行微创手术(MIS),使用机器人、成像技术和数字技术,应用范围涵盖泌尿科、妇科、普外科及胸外科。“精锋”单孔腔镜手术机器人是一种机器人辅助设备,用于通过单个小切口或自然腔道进行微创手术,应用范围涵盖泌尿科、妇科及普外科。该公司在中国国内市场及海外市场开展业务。","exchange":"SEHK","name":"精锋医疗-B","nameEN":"EDGE MEDICAL-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"精锋医疗-B(02675)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供精锋医疗-B(02675)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"精锋医疗-B,02675,精锋医疗-B股票,精锋医疗-B股票老虎,精锋医疗-B股票老虎国际,精锋医疗-B行情,精锋医疗-B股票行情,精锋医疗-B股价,精锋医疗-B股市,精锋医疗-B股票价格,精锋医疗-B股票交易,精锋医疗-B股票购买,精锋医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"精锋医疗-B(02675)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供精锋医疗-B(02675)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}